Structure and expression of the alternatively-spliced forms of mRNA for the mouse homolog of Alzheimer's disease amyloid beta protein precursor

Biochemical and Biophysical Research Communications
T YamadaY Sakaki

Abstract

The human amyloid beta protein (BP) is a major constituent of the amyloid deposited in the brain of patients with Alzheimer's disease and is derived from a larger precursor protein (BPP). In human three alternatively-spliced forms of BPP mRNA were found and two of them were shown to encode a protease inhibitory activity. We have isolated the corresponding species of cDNA in mice and found that the inhibitor domain is highly conserved through mammalian evolution. The homology between human and mouse was 94.6%. Northern blot using specific probes showed that the mRNA for BPP with inhibitor domain was present in every tissue, particularly at a higher level in the kidney. On the other hand, that without inhibitor domain was found most abundantly in the brain but much less in the kidney and the intestine. These data suggest that the individual BPP mRNA species were produced in a tissue-specific manner in mouse as in the case of human.

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C L MastersK Beyreuther

❮ Previous
Next ❯

Citations

May 1, 1994·Journal of Neuroscience Research·P J Gebicke-HaerterM Berger
Mar 1, 1994·Metabolic Brain Disease·A LeBlanc
Nov 30, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Kendra L PuigColin K Combs
Mar 20, 1992·Brain Research. Developmental Brain Research·C A Sherman, G A Higgins
Mar 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·S FisherM L Oster-Granite
Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·W WascoF Solomon
Nov 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·B E Pearson, T K Choi
Jul 1, 1993·The European Journal of Neuroscience·C SolàJ M Palacios
Nov 1, 1995·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A Jiménez-EscrigL Orensanz
Aug 20, 2010·International Journal of Alzheimer's Disease·Radmila Mileusnic, Steven Rose
Aug 31, 1990·Biochemical and Biophysical Research Communications·K YoshikawaK Maruyama
Jun 9, 2007·The Journal of Biological Chemistry·Joanna L JankowskyDavid R Borchelt
Apr 14, 2000·American Journal of Physiology. Gastrointestinal and Liver Physiology·H ItohM Koono
Jun 14, 2000·Molecular and Cellular Neurosciences·M AkaabouneD Hantaï
Dec 30, 1992·Biochemical and Biophysical Research Communications·H Okado, H Okamoto
May 11, 2006·American Journal of Human Genetics·Jessie TheunsChristine Van Broeckhoven

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.